BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16190576)

  • 1. Link between exercise and lower risk for prostate cancer found.
    AVMA Group Health and Life Insurance Trust
    J Am Vet Med Assoc; 2005 Sep; 227(6):858-9. PubMed ID: 16190576
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for prostate cancer.
    Brawley OW; Ankerst DP; Thompson IM
    CA Cancer J Clin; 2009; 59(4):264-73. PubMed ID: 19564245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the value of screening for prostate cancer in the US?
    Albertsen PC
    Nat Clin Pract Oncol; 2005 Nov; 2(11):536-7. PubMed ID: 16270077
    [No Abstract]   [Full Text] [Related]  

  • 4. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
    Barry MJ; Mulley AJ
    J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostate cancer and race.
    Brawley OW; Jani AB; Master V
    Curr Probl Cancer; 2007; 31(3):211-25. PubMed ID: 17543949
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median.
    Loeb S; Nadler RB; Roehl KA; Antenor JA; Catalona WJ
    J Urol; 2007 May; 177(5):1745-8. PubMed ID: 17437803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncertainty and quality of life among men undergoing active surveillance for prostate cancer in the United States and Ireland.
    Hegarty JM; Wallace M; Comber H
    Am J Mens Health; 2008 Jun; 2(2):133-42. PubMed ID: 19477777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise and prostate cancer risk in a cohort of veterans undergoing prostate needle biopsy.
    Antonelli JA; Jones LW; Bañez LL; Thomas JA; Anderson K; Taylor LA; Gerber L; Anderson T; Hoyo C; Grant D; Freedland SJ
    J Urol; 2009 Nov; 182(5):2226-31. PubMed ID: 19758620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recreational physical activity and prostate cancer risk (United States).
    Littman AJ; Kristal AR; White E
    Cancer Causes Control; 2006 Aug; 17(6):831-41. PubMed ID: 16783611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening by prostate-specific antigen and digital rectal examination in relation to prostate cancer mortality. A case-control study.
    Walsh PC
    J Urol; 2005 Nov; 174(5):1824-5. PubMed ID: 16217296
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate cancer in North Carolina.
    Robertson C; Demark-Wahnefried W; Aldrich T
    N C Med J; 1992 Sep; 53(9):447-51. PubMed ID: 1407023
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of colorectal cancer and prostate cancer and impact of radiation therapy.
    Huo D; Hetzel JT; Roy H; Rubin DT
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):1979-85. PubMed ID: 19531678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model of prostate-specific antigen screening outcomes for low- to high-risk men: information to support informed choices.
    Howard K; Barratt A; Mann GJ; Patel MI
    Arch Intern Med; 2009 Sep; 169(17):1603-10. PubMed ID: 19786680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer mortality rates compared to urologist population densities and prostate-specific antigen screening levels on a state-by-state basis in the United States of America.
    Colli JL; Amling CL
    Prostate Cancer Prostatic Dis; 2008; 11(3):247-51. PubMed ID: 18268527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of cardiovascular mortality in prostate cancer patients in the Rotterdam randomized screening trial.
    Otto SJ; Schröder FH; de Koning HJ
    J Clin Oncol; 2006 Sep; 24(25):4184-9. PubMed ID: 16943535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin drugs and risk of advanced prostate cancer.
    Platz EA; Leitzmann MF; Visvanathan K; Rimm EB; Stampfer MJ; Willett WC; Giovannucci E
    J Natl Cancer Inst; 2006 Dec; 98(24):1819-25. PubMed ID: 17179483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer screening: an individual decision.
    Holcomb SS
    Nurse Pract; 2007 Aug; 32(8):6-8. PubMed ID: 17667758
    [No Abstract]   [Full Text] [Related]  

  • 18. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort.
    Rodriguez C; Freedland SJ; Deka A; Jacobs EJ; McCullough ML; Patel AV; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):63-9. PubMed ID: 17179486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is there a basis for prostatic cancer screening in Norway?].
    Høisaeter PA
    Tidsskr Nor Laegeforen; 1997 May; 117(14):2062-5. PubMed ID: 9235689
    [No Abstract]   [Full Text] [Related]  

  • 20. Tocopherols and prostate cancer.
    Cooney RV
    Hawaii Med J; 2006 Sep; 65(9):268-70. PubMed ID: 17153673
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.